Sign in

CIK 0001867096 · Large accelerated filer

Xeris Biopharma Holdings, Inc.

Sign in to watch
Ticker
XERS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
871082097
Phone
844-445-5704
Business address
1375 WEST FULTON STREET, SUITE 1300, CHICAGO, IL, 60607
  1. 4 Insider Changes in Ownership
  2. 4 Insider Changes in Ownership
  3. 4 Insider Changes in Ownership
  4. 4 Insider Changes in Ownership
  5. 4 Insider Changes in Ownership
  6. 4 Insider Changes in Ownership
  7. 4 Insider Changes in Ownership
  8. 8-K Event Shareholder vote results
  9. 4 Insider Changes in Ownership
  10. 424B5 Offering Prospectus
  11. 10-Q Report Quarterly Report
  12. 8-K Event Results of operations
  13. DEFA14A Proxy Proxy Materials
  14. DEFA14A Proxy Proxy Materials
  15. DEF 14A Proxy Proxy Statement
  16. S-8 Other Securities Offered to Employees in Benefit Plans
  17. 10-K Report Annual Report
  18. 8-K Event Material agreement · Results of operations · New debt or obligation · Other events
  19. 4 Insider Changes in Ownership
  20. SC 13G/A Stake Amended Statement of Ownership

Page 14 of 18 · 346 filings